Hemichannels in neurodegenerative diseases: Is there a link to pathology?

Megan Bosch, Tammy L Kielian

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Although originally considered a structural component of gap junctions, connexin hemichannels (HCs) are now recognized as functional entities capable of influencing metabolic gradients within the CNS, allowing direct communication between the intraand extracellular milieus. Besides connexins, HCs can also be formed by pannexins, which are not capable of gap junction assembly. Both positive and negative effects have been attributed to HC activity in the context of neurodegenerative diseases. For example, HCs can exert neuroprotective effects by promoting the uptake of neurotoxic molecules, whereas chronic HC opening can disrupt molecular gradients leading to cellular dysfunction and death. The latter scenario has been suggested for multiple neurodegenerative disorders, including Alzheimer's disease (AD) and more recently, lysosomal storage disorders, which are the focus of this perspective. Currently available evidence suggests a complex role for HCs in neurodegenerative disorders, which sets the stage for future studies to determine whether targeting HC action may improve disease outcomes.

Original languageEnglish (US)
Article number242
JournalFrontiers in Cellular Neuroscience
Volume8
Issue numberAUG
DOIs
StatePublished - Aug 20 2014

Fingerprint

Neurodegenerative Diseases
Connexins
Gap Junctions
Pathology
Neuroprotective Agents
Alzheimer Disease
Communication

Keywords

  • Alzheimer's disease
  • Connexin
  • Hemichannels
  • Lysosomal storage disease
  • Neurodegeneration

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience

Cite this

Hemichannels in neurodegenerative diseases : Is there a link to pathology? / Bosch, Megan; Kielian, Tammy L.

In: Frontiers in Cellular Neuroscience, Vol. 8, No. AUG, 242, 20.08.2014.

Research output: Contribution to journalArticle

@article{e5e50002822540c89eeca6fab7163856,
title = "Hemichannels in neurodegenerative diseases: Is there a link to pathology?",
abstract = "Although originally considered a structural component of gap junctions, connexin hemichannels (HCs) are now recognized as functional entities capable of influencing metabolic gradients within the CNS, allowing direct communication between the intraand extracellular milieus. Besides connexins, HCs can also be formed by pannexins, which are not capable of gap junction assembly. Both positive and negative effects have been attributed to HC activity in the context of neurodegenerative diseases. For example, HCs can exert neuroprotective effects by promoting the uptake of neurotoxic molecules, whereas chronic HC opening can disrupt molecular gradients leading to cellular dysfunction and death. The latter scenario has been suggested for multiple neurodegenerative disorders, including Alzheimer's disease (AD) and more recently, lysosomal storage disorders, which are the focus of this perspective. Currently available evidence suggests a complex role for HCs in neurodegenerative disorders, which sets the stage for future studies to determine whether targeting HC action may improve disease outcomes.",
keywords = "Alzheimer's disease, Connexin, Hemichannels, Lysosomal storage disease, Neurodegeneration",
author = "Megan Bosch and Kielian, {Tammy L}",
year = "2014",
month = "8",
day = "20",
doi = "10.3389/fncel.2014.00242",
language = "English (US)",
volume = "8",
journal = "Frontiers in Cellular Neuroscience",
issn = "1662-5102",
publisher = "Frontiers Research Foundation",
number = "AUG",

}

TY - JOUR

T1 - Hemichannels in neurodegenerative diseases

T2 - Is there a link to pathology?

AU - Bosch, Megan

AU - Kielian, Tammy L

PY - 2014/8/20

Y1 - 2014/8/20

N2 - Although originally considered a structural component of gap junctions, connexin hemichannels (HCs) are now recognized as functional entities capable of influencing metabolic gradients within the CNS, allowing direct communication between the intraand extracellular milieus. Besides connexins, HCs can also be formed by pannexins, which are not capable of gap junction assembly. Both positive and negative effects have been attributed to HC activity in the context of neurodegenerative diseases. For example, HCs can exert neuroprotective effects by promoting the uptake of neurotoxic molecules, whereas chronic HC opening can disrupt molecular gradients leading to cellular dysfunction and death. The latter scenario has been suggested for multiple neurodegenerative disorders, including Alzheimer's disease (AD) and more recently, lysosomal storage disorders, which are the focus of this perspective. Currently available evidence suggests a complex role for HCs in neurodegenerative disorders, which sets the stage for future studies to determine whether targeting HC action may improve disease outcomes.

AB - Although originally considered a structural component of gap junctions, connexin hemichannels (HCs) are now recognized as functional entities capable of influencing metabolic gradients within the CNS, allowing direct communication between the intraand extracellular milieus. Besides connexins, HCs can also be formed by pannexins, which are not capable of gap junction assembly. Both positive and negative effects have been attributed to HC activity in the context of neurodegenerative diseases. For example, HCs can exert neuroprotective effects by promoting the uptake of neurotoxic molecules, whereas chronic HC opening can disrupt molecular gradients leading to cellular dysfunction and death. The latter scenario has been suggested for multiple neurodegenerative disorders, including Alzheimer's disease (AD) and more recently, lysosomal storage disorders, which are the focus of this perspective. Currently available evidence suggests a complex role for HCs in neurodegenerative disorders, which sets the stage for future studies to determine whether targeting HC action may improve disease outcomes.

KW - Alzheimer's disease

KW - Connexin

KW - Hemichannels

KW - Lysosomal storage disease

KW - Neurodegeneration

UR - http://www.scopus.com/inward/record.url?scp=84926148953&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84926148953&partnerID=8YFLogxK

U2 - 10.3389/fncel.2014.00242

DO - 10.3389/fncel.2014.00242

M3 - Article

C2 - 25191227

AN - SCOPUS:84926148953

VL - 8

JO - Frontiers in Cellular Neuroscience

JF - Frontiers in Cellular Neuroscience

SN - 1662-5102

IS - AUG

M1 - 242

ER -